It is a pharma private limited company based in Mohali, Punjab, India, established in 2021.
2021 | Mohali, Punjab, India | ActiveNoxxon Pharmaceuticals Private Limited, a active private limited company, was established on 07 June 2021 in Mohali, Punjab, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239PB2021PTC053565. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Satish Kumar Bansal (Director), Sahil Bansal (Director). It holds ₹4.00 M open charges and ₹3.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at #644 B Phase Xi Sector 65, Mohali, Punjab, 160062.
U24239PB2021PTC053565
053565
07 June 2021
₹0.10 M
₹0.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Noxxon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satish Kumar Bansal | Director | 07 Jun 2021 | Current |
| Sahil Bansal | Director | 07 Jun 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Noxxon Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Noxxon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹4,000,000.00
₹3,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Feb 2024 | Hdfc Bank Limited | ₹4.00 M | Open |
| 19 Feb 2022 | Others | ₹3.00 M | Satisfied |
Explore comprehensive loan charge details -
Noxxon Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Noxxon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noxxon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Noxxon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Noxxon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 4.00 M with Charge ID 100875619 was registered on 17 Feb 2024. was documented.
A charge registered on 19 Feb 2022 via Charge ID 100536667 with Others was fully satisfied on 19 Jan 2024. was recorded as a recent event.
A charge with Others amounted to Rs. 3.00 M with Charge ID 100536667 was registered on 19 Feb 2022. was recorded as a recent event.
Satish Kumar Bansal was appointed as a Director was appointed as a Director on 07 Jun 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.
The CIN of Noxxon Pharmaceuticals Private Limited is U24239PB2021PTC053565.
Noxxon Pharmaceuticals Private Limited is headquartered at #644 B Phase Xi Sector 65, Mohali, Punjab, 160062.
Noxxon Pharmaceuticals Private Limited was incorporated on 07 June 2021.
The current directors of Noxxon Pharmaceuticals Private Limited are
The primary industry of Noxxon Pharmaceuticals Private Limited is Pharma.
Noxxon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Noxxon Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX